N.S. to receive 13,000 AstraZeneca vaccine doses next week, reports three new cases

·1 min read

HALIFAX — Nova Scotia will get 13,000 doses of the newly approved Oxford-AstraZeneca COVID-19 vaccine next week.

Health officials said today the upcoming shipment must be used by April 2 and therefore all 13,000 doses will be administered to residents across the province aged 50 to 64 years starting March 15.

The vaccine will be given out at 26 locations in Nova Scotia on a first come, first served basis. Canada's National Advisory Committee on Immunization recommended Tuesday that it not be administered to people 65 years of age or older.

Oxford-AstraZeneca’s vaccine was found to be 62 per cent effective in clinical trials, unlike the Moderna and Pfizer-BioNtech vaccines, which boast effectiveness rates of over 90 per cent.

Officials say the delivery of the new vaccine won’t interfere with the scheduled rollout of the Moderna and Pfizer-BioNtech vaccines for people aged 80 years and up.

Health officials in Nova Scotia reported three new cases of COVID-19 today, all of which involve close contacts of previously reported cases.

This report by The Canadian Press was first published March 3, 2021.

— — —

This story was produced with the financial assistance of the Facebook and Canadian Press News Fellowship.

The Canadian Press